Researchers have used Retatrutide to evaluate how GIP receptor activation contributes to broader endocrine system interactions
Zhang J, Ou C, Chen M
www.pharmacytimes.com News|Articles|October 14, 2025 GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders Author(s) Kennedy Ferruggia, Assistant Editor Listen 0:00 / 4:56 Key Takeaways GLP-1 receptor agonists may treat alcohol and substance use disorders by modulating addiction-related neurobiological pathways, reducing cravings and substance use
BPC-157 stands for Body Protection Compound-157, a peptide derived from a naturally occurring protein in the stomach
So, if a patient is already fasting and their electrolytes are changing, and then they get a vasoactive drip, this could theoretically cause sudden low blood pressure and unstable heart rhythms, which could lead to cardiac arrest, though this is very rare.These IV treatments are not just beauty hacks, they work like strong medications